Regional sensitisation workshop on Newcastle Disease control in village poultry in West Africa

A two-day workshop on Newcastle disease (ND) control in West and Central Africa brought together 38 representatives from the government and private sectors to discuss key challenges and potential interventions in the vaccine delivery and administration in the regions. The event, which ran from 29-30 June 2017 in Ouagadougou, Burkina Faso, included presentations, discussions and […]

World Zoonoses Day: Spotlight on the most common zoonotic disease

July 6th: Today is World Zoonoses Day – a date that has particular relevance in light of the global Brucellosis Vaccine Prize, a US $30 million prize competition inviting vaccine developers to submit proposals for – and ultimately develop – a suitable vaccine for use against Brucella melitensis in small ruminants across the developing world. […]

Experts take stock of the East Coast Fever vaccine performance in Uganda

On June 8, 2017, the Global Alliance for Livestock Veterinary Medicines (GALVmed) convened a workshop in Kampala, Uganda, aimed at presenting the findings on the safety and protection of East Coast Fever-Infection Treatment Method (ECF-ITM) vaccine at farm level in the country. The findings were from an on-farm ECF-ITM study in Uganda supported by GALVmed […]

Researchers on a mission to improve the East Coast Fever vaccine

GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection and Treatment Method (ITM)  was developed in mid-70s and since then new tools have been developed   to characterise the vaccine strains/stocks and provide new knowledge to make it […]

Bringing the benefits of the ECF vaccine to Rwandan farmers

Rwandan farmers will soon have a reason to smile as they will be able to protect their cattle from one of the deadliest cattle diseases – East Coast Fever. The disease that kills numerous cattle across the East Africa region is present in most regions of Rwanda and yet unlike their East African counterparts, Rwandan […]

A novel initiative for a new brucellosis vaccine

A new US $30 million initiative was launched in June 2016 to offer a solution to a sheep and goat disease that is transmitted to over 500,000 people per year worldwide. The prize is one of the largest of its kind and is funded by AgResults, a collaborative multi-donor initiative between the Australian, Canadian, UK and US governments […]

Viewpoints @ Brucellosis Vaccine Prize launch: Reaction to prize competition

What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Gwyn Jones, Chairman of the Responsible Use of Medicines in Agriculture Alliance (RUMA) UK responds with his personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition […]

Viewpoints @ Brucellosis Vaccine Prize launch: Reaction to prize competition

What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Peter Oostenbach, Associate Director for Global Public Policy Animal Health at Merck Animal Health/MSD Animal Health responds with his personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US $30 million […]

Viewpoints @ Brucellosis Vaccine Prize launch: Why a vaccine is important

Why is a vaccine against B. melitensis important? George Tice, Senior Director of Market Access for Europe, Middle East and Africa at Elanco Animal Health responds with his personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition aimed at incentivising animal health companies to […]

Viewpoints @ Brucellosis Vaccine Prize launch: Potential impact on untreated diseases

If the Brucellosis Vaccine Prize Competition results in a vaccine, do you think companies could start looking at diseases that remain untreated? Brigitte Boenisch, Head of Regulatory Affairs for Europe, Middle East and Africa at Merial responds with her personal view. —————————————————————————————————- GALVmed and AgResults announced the launch of the Brucellosis Vaccine Initiative, a US […]